3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Multiple Myeloma
800
Precursor Cell Lymphoblastic Leukemia-Lymphoma
169
Recurrence
140
Neoplasms, Plasma Cell
110
Lymphoma
93
Leukemia
91
Neoplasms
81
Burkitt Lymphoma
57
Vomiting
51
Lymphoma, Non-Hodgkin
50
Immunoglobulin Light-chain Amyloidosis
49
Lymphoma, Large B-Cell, Diffuse
44
Nausea
38
Lymphoma, Mantle-Cell
38
Prostatic Neoplasms
31
Lymphoma, Follicular
30
Hodgkin Disease
29
Waldenstrom Macroglobulinemia
27
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
27
Neoplasm Metastasis
26
Leukemia, Lymphocytic, Chronic, B-Cell
26
Carcinoma, Non-Small-Cell Lung
26
Leukemia, Myeloid, Acute
25
Breast Neoplasms
25
Lung Neoplasms
22
Amyloidosis
21
Leukemia, Biphenotypic, Acute
18
Lymphoma, B-Cell, Marginal Zone
17
Lymphoma, Extranodal NK-T-Cell
16
Smoldering Multiple Myeloma
15
Interventions
Carboplatin
5
Paclitaxel
4
pembrolizumab
3
Educational Status
3
niraparib
2
anlotinib
2
Therapeutic Touch
2
Pemetrexed
2
Palliative Care
2
Nivolumab
2
Methods
2
Gemcitabine
2
Early Intervention, Educational
2
Bevacizumab
2
temsirolimus
1
rucaparib
1
relacorilant
1
olaparib
1
nintedanib
1
nilotinib
1
liposomal doxorubicin
1
lenvatinib
1
fosaprepitant
1
atezolizumab
1
argatroban
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Topotecan
1
Thrombopoietin
1
Surveys and Questionnaires
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Genital Neoplasms, Female
×
Dexamethasone
×
Clear all
NCT01074697
2015-04-24
GAND-emesis
Odense University Hospital
Phase 3
Completed
246 enrolled